BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11738748)

  • 1. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers.
    Bumann D; Metzger WG; Mansouri E; Palme O; Wendland M; Hurwitz R; Haas G; Aebischer T; von Specht BU; Meyer TF
    Vaccine; 2001 Dec; 20(5-6):845-52. PubMed ID: 11738748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
    Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
    Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers.
    DiPetrillo MD; Tibbetts T; Kleanthous H; Killeen KP; Hohmann EL
    Vaccine; 1999 Oct; 18(5-6):449-59. PubMed ID: 10519934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines.
    Aebischer T; Bumann D; Epple HJ; Metzger W; Schneider T; Cherepnev G; Walduck AK; Kunkel D; Moos V; Loddenkemper C; Jiadze I; Panasyuk M; Stolte M; Graham DY; Zeitz M; Meyer TF
    Gut; 2008 Aug; 57(8):1065-72. PubMed ID: 18417532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.
    Londoño-Arcila P; Freeman D; Kleanthous H; O'Dowd AM; Lewis S; Turner AK; Rees EL; Tibbitts TJ; Greenwood J; Monath TP; Darsley MJ
    Infect Immun; 2002 Sep; 70(9):5096-106. PubMed ID: 12183559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immune response towards recombinant Helicobacter pylori urease and cellular fractions.
    Voland P; Zeitner M; Hafsi N; Prinz C
    Vaccine; 2006 May; 24(18):3832-9. PubMed ID: 16122847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine.
    Salerno-Goncalves R; Pasetti MF; Sztein MB
    J Immunol; 2002 Aug; 169(4):2196-203. PubMed ID: 12165550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic immune responses to oral administration of recombinant attenuated Salmonella typhimurium expressing Helicobacter pylori urease in mice.
    Liu XF; Hu JL; Quan QZ; Sun ZQ; Wang YJ; Qi F
    World J Gastroenterol; 2005 Apr; 11(14):2154-6. PubMed ID: 15810083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers.
    Angelakopoulos H; Hohmann EL
    Infect Immun; 2000 Apr; 68(4):2135-41. PubMed ID: 10722611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
    Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
    Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Yang XL; Liu WC; Yang WW; Zhong D; Liu YH; Zhang JD; Jiang JH; Li SS
    Biomed Environ Sci; 2005 Dec; 18(6):411-8. PubMed ID: 16544523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.
    Liu KY; Shi Y; Luo P; Yu S; Chen L; Zhao Z; Mao XH; Guo G; Wu C; Zou QM
    Vaccine; 2011 Sep; 29(38):6679-85. PubMed ID: 21745524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of the live vaccine strain Salmonella enterica serovar Typhi Ty21a for antigen delivery via the hemolysin secretion system of Escherichia coli.
    Hotz C; Fensterle J; Goebel W; Meyer SR; Kirchgraber G; Heisig M; Fürer A; Dietrich G; Rapp UR; Gentschev I
    Int J Med Microbiol; 2009 Feb; 299(2):109-19. PubMed ID: 18706861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits.
    Corthésy-Theulaz IE; Hopkins S; Bachmann D; Saldinger PF; Porta N; Haas R; Zheng-Xin Y; Meyer T; Bouzourène H; Blum AL; Kraehenbuhl JP
    Infect Immun; 1998 Feb; 66(2):581-6. PubMed ID: 9453612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Liu X; Hu J; Zhang X; Fan D
    Chin Med J (Engl); 2002 Oct; 115(10):1513-6. PubMed ID: 12490099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice.
    Lee MH; Roussel Y; Wilks M; Tabaqchali S
    Vaccine; 2001 Jul; 19(28-29):3927-35. PubMed ID: 11427267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model.
    Guo L; Yin R; Liu K; Lv X; Li Y; Duan X; Chu Y; Xi T; Xing Y
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3495-507. PubMed ID: 24370888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.
    Guo L; Liu K; Zhao W; Li X; Li T; Tang F; Zhang R; Wu W; Xi T
    Appl Microbiol Biotechnol; 2013 Mar; 97(6):2367-78. PubMed ID: 23064457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.